- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-22-0255768

Ridrim Pharmaceutical Private Limited
About Ridrim Pharmaceutical Private Limited
Data last updated:
Ridrim Pharmaceutical Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 September 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85100GJ2022PTC135558.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Laxmanbhai Vasharambhai Sakariya and Kashyap Pinakinbhai Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bld – J Flat 403 Shantiniketan Flora Mota Varachha, Surat, Gujarat, India – 394101.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.94 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.33 Lakh (net margin 0.9%) and EBITDA of ₹4.51 Lakh (EBITDA margin 0.9%).
Ridrim Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0255768).
Company details
Recognitions & Rankings of Ridrim Pharmaceutical
Contact details
Ridrim Pharmaceutical Private Limited's registered office is in Surat, Gujarat.
- Registered AddressBld – J Flat 403 Shantiniketan Flora Mota Varachha, Surat, Gujarat, India – 394101
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ridrim Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ridrim Pharmaceutical Private Limited, buy the company report.
Financials of Ridrim Pharmaceutical Private Limited
FY 2025 filings availableRidrim Pharmaceutical Private Limited reported revenue of ₹4.94 Cr (up 589% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 589% in the latest year. EBITDA rose 205% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹4.51 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹4.33 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.9% | |
| Net Profit Margin | 0.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ridrim Pharmaceutical Private Limited, buy the company report.
Board of directors of Ridrim Pharmaceutical Private Limited
Ridrim Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laxmanbhai Vasharambhai Sakariya Also directs: Sakariya Exim LLP | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Kashyap Pinakinbhai Vyas | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Arvindbhai Manjibhai Mangukiya | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Rameshbhai Manjibhai Mangukiya Also directs: Krishvi Gems Private Limited | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Ridrim Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Carenow Medical Private Limited | ₹4.95 Cr (FY 2025) | -6.0% | Coimbatore, Tamil Nadu, India | |||
| NRJ Pharmachem Private Limited | ₹4.95 Cr (FY 2025) | 47.0% | Navi Mumbai, Maharashtra, India | |||
| Elikem Nutra Private Limited | ₹4.95 Cr (FY 2025) | 92.0% | Rakanpur, Gujarat, India | |||
| Highgrow Floris Chemicals Private Limited | ₹4.94 Cr (FY 2025) | 82.0% | Hyderabad, Telangana, India | |||
| Uttranchal Pharmaceuticals Private Limited | ₹4.94 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Ridrim Pharmaceutical Private Limitedthis company | ₹4.94 Cr (FY 2024) | ₹4.33 Lakh | 0.9% | 589.0% | Surat, Gujarat, India | |
| Lewis Bioserch Pharma Private Limited | ₹4.94 Cr (FY 2024) | 19.0% | Chandigarh, India | |||
| Geekay Speciality Chemicals (India) Private Limited | ₹4.94 Cr (FY 2024) | 39.0% | Thrissur, Kerala, India | |||
| Cataliq Laboratories Private Limited | ₹4.94 Cr (FY 2024) | -12.0% | Ahmedabad, Gujarat, India | |||
| Corerx Pharma India Private Limited | ₹4.94 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| Karlin Pharmaceuticals & Exports Private Limited | ₹4.93 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Ridrim Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ridrim Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ridrim Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ridrim Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ridrim Pharmaceutical Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Arvindbhai Manjibhai Mangukiya was appointed as Director on 19 Sep 2022.
Frequently asked questions
Ridrim Pharmaceutical is an active private limited company based in Surat, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 September 2022 (4+ years old) and is registered under CIN U85100GJ2022PTC135558.
Ridrim Pharmaceutical has 4 current directors:
- Laxmanbhai Vasharambhai Sakariya - Director
- Kashyap Pinakinbhai Vyas - Director
- Arvindbhai Manjibhai Mangukiya - Director
- Rameshbhai Manjibhai Mangukiya - Director
The latest financial statements of Ridrim Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Ridrim Pharmaceutical is U85100GJ2022PTC135558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ridrim Pharmaceutical was incorporated on 19 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ridrim Pharmaceutical by revenue are Carenow Medical Private Limited, NRJ Pharmachem Private Limited, Elikem Nutra Private Limited, Highgrow Floris Chemicals Private Limited, Uttranchal Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arvindbhai Manjibhai Mangukiya was appointed as Director on 19 Sep 2022. Kashyap Pinakinbhai Vyas was appointed as Director on 19 Sep 2022. Laxmanbhai Vasharambhai Sakariya was appointed as Director on 19 Sep 2022. Ridrim Pharmaceutical has 4 board changes on record in total.
Yes, Ridrim Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0255768).
The registered office of Ridrim Pharmaceutical is at Bld – J Flat 403 Shantiniketan Flora Mota Varachha, Surat, Gujarat, India – 394101.
Ridrim Pharmaceutical operates in the pharma industry, in the api manufacturers segment.
Ridrim Pharmaceutical can be reached at its registered office: Bld – J Flat 403 Shantiniketan Flora Mota Varachha, Surat, Gujarat, India – 394101.

